PACIRA BIOSCIENCES, INC. Increase (Decrease) in Accounts Receivable
PACIRA BIOSCIENCES, INC. (PCRX) reported Increase (Decrease) in Accounts Receivable of $12.07 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-04
- PACIRA BIOSCIENCES, INC. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $10.51M, a 9.39% increase year-over-year.
- PACIRA BIOSCIENCES, INC. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $1.57M.
- PACIRA BIOSCIENCES, INC. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $8.80M, a 30.45% decline year-over-year.
- PACIRA BIOSCIENCES, INC. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $897.00K.
- PACIRA BIOSCIENCES, INC. increase (decrease) in accounts receivable for fiscal 2025 was $10.74M, a 38.64% increase from fiscal 2024.
- PACIRA BIOSCIENCES, INC. increase (decrease) in accounts receivable for fiscal 2024 was $7.75M, a 8.23% increase from fiscal 2023.
- PACIRA BIOSCIENCES, INC. increase (decrease) in accounts receivable for fiscal 2023 was $7.16M, a 244.35% increase from fiscal 2022.
- PACIRA BIOSCIENCES, INC. increase (decrease) in accounts receivable for fiscal 2022 was $2.08M, a 80.07% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $10.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $12.07M 10-Q · filed 2026-08-04 | $20.87M derived: sum of 3 quarters · filed 2026-08-04 | $21.77M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $1.57M 10-Q · filed 2026-04-30 | $10.37M derived: sum of 2 quarters · filed 2026-04-30 | $11.26M derived: sum of 3 quarters · filed 2026-04-30 | $20.87M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $8.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $9.70M derived: sum of 2 quarters · filed 2026-02-26 | $19.30M derived: sum of 3 quarters · filed 2026-08-04 | $10.74M 10-K · filed 2026-02-26 |
| 2025-09-30 | $897.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $10.50M derived: sum of 2 quarters · filed 2026-08-04 | $1.94M 10-Q · filed 2025-11-06 | $14.59M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $9.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $1.05M 10-Q · filed 2026-08-04 | $13.70M derived: sum of 3 quarters · filed 2026-08-04 | $9.57M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | -$8.56M 10-Q · filed 2026-04-30 | $4.09M derived: sum of 2 quarters · filed 2026-04-30 | -$35.00K derived: sum of 3 quarters · filed 2026-04-30 | $3.11M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $12.65M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $8.52M derived: sum of 2 quarters · filed 2026-02-26 | $11.66M derived: sum of 3 quarters · filed 2026-02-26 | $7.75M 10-K · filed 2026-02-26 |
| 2024-09-30 | -$4.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$986.00K derived: sum of 2 quarters · filed 2025-11-06 | -$4.90M 10-Q · filed 2025-11-06 | $3.70M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $3.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$776.00K 10-Q · filed 2025-08-05 | $7.82M derived: sum of 3 quarters · filed 2026-02-26 | $5.70M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | -$3.92M 10-Q · filed 2025-05-08 | $4.68M derived: sum of 2 quarters · filed 2026-02-26 | $2.56M derived: sum of 3 quarters · filed 2026-02-26 | $8.43M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $8.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $6.48M derived: sum of 2 quarters · filed 2026-02-26 | $12.35M derived: sum of 3 quarters · filed 2026-02-26 | $7.16M 10-K · filed 2026-02-26 |
| 2023-09-30 | -$2.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $3.75M derived: sum of 2 quarters · filed 2024-11-06 | -$1.44M 10-Q · filed 2024-11-06 | $3.49M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $5.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30 | $683.00K 10-Q · filed 2024-07-30 | $5.61M derived: sum of 3 quarters · filed 2025-02-27 | $7.97M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | -$5.19M 10-Q · filed 2024-05-07 | -$266.00K derived: sum of 2 quarters · filed 2025-02-27 | $2.10M derived: sum of 3 quarters · filed 2025-02-27 | $1.10M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $4.93M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $7.29M derived: sum of 2 quarters · filed 2025-02-27 | $6.29M derived: sum of 3 quarters · filed 2025-02-27 | $2.08M 10-K · filed 2025-02-27 |
| 2022-09-30 | $2.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $1.37M derived: sum of 2 quarters · filed 2023-11-02 | -$2.85M 10-Q · filed 2023-11-02 | $10.66M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | -$998.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | -$5.21M 10-Q · filed 2023-08-02 | $8.29M derived: sum of 3 quarters · filed 2024-02-29 | -$10.09M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | -$4.21M 10-Q · filed 2023-05-03 | $9.29M derived: sum of 2 quarters · filed 2024-02-29 | -$9.09M derived: sum of 3 quarters · filed 2024-02-29 | $6.68M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $13.50M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$4.88M derived: sum of 2 quarters · filed 2024-02-29 | $10.90M derived: sum of 3 quarters · filed 2024-02-29 | $10.43M 10-K · filed 2024-02-29 |
| 2021-09-30 | -$18.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$2.61M derived: sum of 2 quarters · filed 2022-11-03 | -$3.07M 10-Q · filed 2022-11-03 | $3.83M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $15.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $15.31M 10-Q · filed 2022-08-03 | $22.21M derived: sum of 3 quarters · filed 2023-02-28 | $24.34M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | -$462.00K 10-Q · filed 2022-05-04 | $6.44M derived: sum of 2 quarters · filed 2023-02-28 | $8.57M derived: sum of 3 quarters · filed 2023-02-28 | $13.60M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $6.90M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $9.03M derived: sum of 2 quarters · filed 2023-02-28 | $14.06M derived: sum of 3 quarters · filed 2023-02-28 | $5.52M 10-K · filed 2023-02-28 |
| 2020-09-30 | $2.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $7.16M derived: sum of 2 quarters · filed 2021-11-03 | -$1.39M 10-Q · filed 2021-11-03 | $3.57M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $5.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | -$3.52M 10-Q · filed 2021-08-03 | $1.44M derived: sum of 3 quarters · filed 2022-02-28 | $2.87M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | -$8.54M 10-Q · filed 2021-05-04 | -$3.58M derived: sum of 2 quarters · filed 2022-02-28 | -$2.16M derived: sum of 3 quarters · filed 2022-02-28 | -$1.78M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $4.96M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $6.38M derived: sum of 2 quarters · filed 2022-02-28 | $6.76M derived: sum of 3 quarters · filed 2022-02-28 | $8.52M 10-K · filed 2022-02-28 |
| 2019-09-30 | $1.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-30 | $1.80M derived: sum of 2 quarters · filed 2020-10-30 | $3.57M 10-Q · filed 2020-10-30 | $7.30M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $375.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $2.14M 10-Q · filed 2020-08-06 | $5.88M derived: sum of 3 quarters · filed 2021-03-01 | $4.50M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $1.77M 10-Q · filed 2020-05-07 | $5.50M derived: sum of 2 quarters · filed 2021-03-01 | $4.13M derived: sum of 3 quarters · filed 2021-03-01 | $8.56M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $3.73M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $2.36M derived: sum of 2 quarters · filed 2021-03-01 | $6.80M derived: sum of 3 quarters · filed 2021-03-01 | $6.00M 10-K · filed 2021-03-01 |
| 2018-09-30 | -$1.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $3.06M derived: sum of 2 quarters · filed 2019-11-08 | $2.27M 10-Q · filed 2019-11-08 | $6.90M derived: sum of 4 quarters · filed 2020-02-21 |
| 2018-06-30 | $4.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $3.64M 10-Q · filed 2019-08-08 | $8.28M derived: sum of 3 quarters · filed 2020-02-21 | $7.83M derived: sum of 4 quarters · filed 2020-02-21 |
| 2018-03-31 | -$798.00K 10-Q · filed 2019-05-02 | $3.84M derived: sum of 2 quarters · filed 2020-02-21 | $3.39M derived: sum of 3 quarters · filed 2020-02-21 | $3.16M derived: sum of 4 quarters · filed 2020-02-21 |
| 2017-12-31 | $4.64M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | $4.19M derived: sum of 2 quarters · filed 2020-02-21 | $3.96M derived: sum of 3 quarters · filed 2020-02-21 | $1.72M 10-K · filed 2020-02-21 |
| 2017-09-30 | -$446.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | -$681.00K derived: sum of 2 quarters · filed 2018-11-01 | -$2.92M 10-Q · filed 2018-11-01 | $256.00K derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | -$235.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | -$2.47M 10-Q · filed 2018-08-02 | $702.00K derived: sum of 3 quarters · filed 2019-02-28 | -$1.18M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | -$2.23M 10-Q · filed 2018-05-03 | $937.00K derived: sum of 2 quarters · filed 2019-02-28 | -$949.00K derived: sum of 3 quarters · filed 2019-02-28 | $1.80M derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | $3.17M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $1.29M derived: sum of 2 quarters · filed 2019-02-28 | $4.04M derived: sum of 3 quarters · filed 2019-02-28 | $4.08M 10-K · filed 2019-02-28 |
| 2016-09-30 | -$1.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $864.00K derived: sum of 2 quarters · filed 2017-11-08 | $910.00K 10-Q · filed 2017-11-08 | $846.00K derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-06-30 | $2.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | $2.80M 10-Q · filed 2017-08-02 | $2.73M derived: sum of 3 quarters · filed 2018-02-28 | $4.37M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-03-31 | $46.00K 10-Q · filed 2017-05-04 | -$18.00K derived: sum of 2 quarters · filed 2018-02-28 | $1.62M derived: sum of 3 quarters · filed 2018-02-28 | $1.39M derived: sum of 4 quarters · filed 2018-02-28 |
| 2015-12-31 | -$64.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $1.57M derived: sum of 2 quarters · filed 2018-02-28 | $1.34M derived: sum of 3 quarters · filed 2018-02-28 | $3.49M 10-K · filed 2018-02-28 |
| 2015-09-30 | $1.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $1.41M derived: sum of 2 quarters · filed 2016-11-02 | $3.55M 10-Q · filed 2016-11-02 | $11.33M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | -$230.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $1.92M 10-Q · filed 2016-08-04 | $9.69M derived: sum of 3 quarters · filed 2017-03-01 | $9.66M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $2.15M 10-Q · filed 2016-05-02 | $9.92M derived: sum of 2 quarters · filed 2017-03-01 | $9.89M derived: sum of 3 quarters · filed 2017-03-01 | $14.47M derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | $7.78M 10-K · filed 2017-03-01 | $7.75M derived: sum of 2 quarters · filed 2017-03-01 | $12.32M derived: sum of 3 quarters · filed 2017-03-01 | $7.78M 10-K · filed 2016-02-25 |
| 2014-09-30 | -$28.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-27 | $4.55M derived: sum of 2 quarters · filed 2015-10-27 | $5.93M 10-Q · filed 2015-10-27 | $10.75M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-06-30 | $4.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | $5.96M 10-Q · filed 2015-07-30 | $10.77M derived: sum of 3 quarters · filed 2016-02-25 | $12.79M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-03-31 | $1.38M 10-Q · filed 2015-04-30 | $6.20M derived: sum of 2 quarters · filed 2016-02-25 | $8.21M derived: sum of 3 quarters · filed 2016-02-25 | $10.73M derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-12-31 | $4.82M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $6.83M derived: sum of 2 quarters · filed 2016-02-25 | $9.35M derived: sum of 3 quarters · filed 2016-02-25 | $10.24M 10-K · filed 2016-02-25 |
| 2013-09-30 | $2.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $4.53M derived: sum of 2 quarters · filed 2014-10-30 | $5.42M 10-Q · filed 2014-10-30 | $7.31M derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-06-30 | $2.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $3.40M 10-Q · filed 2014-07-31 | $5.30M derived: sum of 3 quarters · filed 2015-02-24 | $4.54M derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-03-31 | $891.00K 10-Q · filed 2014-05-01 | $2.78M derived: sum of 2 quarters · filed 2015-02-24 | $2.03M derived: sum of 3 quarters · filed 2015-02-24 | $4.38M derived: sum of 4 quarters · filed 2015-02-24 |
| 2012-12-31 | $1.89M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $1.14M derived: sum of 2 quarters · filed 2015-02-24 | $3.49M derived: sum of 3 quarters · filed 2015-02-24 | $2.24M 10-K · filed 2015-02-24 |
| 2012-09-30 | -$755.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-31 | $1.60M derived: sum of 2 quarters · filed 2013-10-31 | $346.00K 10-Q · filed 2013-10-31 | $963.00K derived: sum of 4 quarters · filed 2014-02-25 |
| 2012-06-30 | $2.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $1.10M 10-Q · filed 2013-08-06 | $1.72M derived: sum of 3 quarters · filed 2014-02-25 | $2.16M derived: sum of 4 quarters · filed 2014-02-25 |
| 2012-03-31 | -$1.25M 10-Q · filed 2013-05-08 | -$636.00K derived: sum of 2 quarters · filed 2014-02-25 | -$195.00K derived: sum of 3 quarters · filed 2014-02-25 | -$950.00K derived: sum of 4 quarters · filed 2014-02-25 |
| 2011-12-31 | $617.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $1.06M derived: sum of 2 quarters · filed 2014-02-25 | $303.00K derived: sum of 3 quarters · filed 2014-02-25 | $922.00K 10-K · filed 2014-02-25 |
| 2011-09-30 | $441.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01 | -$314.00K derived: sum of 2 quarters · filed 2012-11-01 | $305.00K 10-Q · filed 2012-11-01 | -$1.03M derived: sum of 4 quarters · filed 2013-03-07 |
| 2011-06-30 | -$755.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | -$136.00K 10-Q · filed 2012-08-09 | -$1.48M derived: sum of 3 quarters · filed 2013-03-07 | -$2.20M derived: sum of 4 quarters · filed 2013-03-07 |
| 2011-03-31 | $619.00K 10-Q · filed 2012-05-09 | -$721.00K derived: sum of 2 quarters · filed 2013-03-07 | -$1.45M derived: sum of 3 quarters · filed 2013-03-07 | |
| 2010-12-31 | -$1.34M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-07 | -$2.06M derived: sum of 2 quarters · filed 2013-03-07 | -$264.00K 10-K · filed 2013-03-07 | |
| 2010-09-30 | -$724.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-31 | $1.08M 10-Q · filed 2011-10-31 | ||
| 2010-06-30 | $1.80M 10-Q · filed 2011-08-11 | |||
| 2009-12-31 | -$1.13M 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |